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Implication for health policy/practice/research/medical education:
VOs extracted from Premna odorata have anti-TB activity by acting on TLR-4/NFκB signaling pathway through decreasing 
the serum levels of TNF-α, IFN-γ, IL1-β and the mRNA expression levels of TLR-4 & NF-κB, and increasing IL-10 & TAC. 
Understanding the mechanism and the signaling pathway involving in the anti-tuberculosis activity will help a lot in preparation 
of new drugs against TB.
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Introduction: The development of multi drug resistant (MDR) tuberculosis (TB) and 
extensively drug resistant (XDR) TB, increased the interest in the usage of medicinal plants 
that are complementary to antibiotics to improve anti-TB efficacy. The present study aimed 
to confirm the anti-TB efficacy of volatile oils (VOs) isolated from different parts of Premna 
odorata in vivo, and moreover, to test the possible involvement of TLR4/NF-κB signaling 
pathway in its anti-TB efficacy. 
Methods: Thirty mice were divided into six equal groups. Group 1: healthy mice (negative 
control). Groups 2-6 were injected intravenously with a positive TB solution of purified 
MeDiPro Mycobacterium tuberculosis (MTB) antigen for 7 days to induce tuberculosis. Group 
3-6: TB-injected mice treated respectively with leaves VO (300 μL/d), young stems VO (300 
μL/d), flowers VO and a combination of the three essential VOs (1:1:1). Various immunologic 
factors and antioxidant activity were evaluated and compared in the groups.
Results: TB-infected mice showed a significant increase in the serum levels of tumor necrosis 
factor-α (TNF-α), interferon-gamma (IFN-γ), interleukin (IL) 1-β and the mRNA expression 
levels of toll-like receptor 4 (TLR-4) & nuclear factor-κB (NF-κB) and a decrease in IL-10 & total 
antioxidant capacity (TAC). While pretreatment with VOs extracted from leaves, flowers, young 
stems and a combination of the three oils reversed these effects. 
Conclusion: The immunomodulatory effects of VOs extracted from different parts of P. odorata 
against TB infection involve the TLR-4/NFκB signaling pathway as well as, antioxidant effects, 
recommending that the use of this plant may help TB infected patients.
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A B S T R A C T
Introduction
Tuberculosis (TB), which is a long-lasting transmittable 
disease caused by the bacillus Mycobacterium tuberculosis, 
has existed for millennia and persists as a major worldwide 
health threat. The pulmonary as well as extra pulmonary 
TB, cause ill-health in about 10 million people each year 
and is one of the highest ten causes of death globally. For 
the previous 5 years, it has been the foremost cause of 
death from a single contagious agent, ranking above HIV/
AIDS (1). For that reason, TB stays a significant public 
health threat internationally, mandating a serious need 
to develop new anti-TB agents that are helpful in the 
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treatment of active and latent TB.
The atypical cell wall of M. tuberculosis defends it from the 
digestion of macrophages and gives it an innate resistance 
to many antibiotics (2,3). Multiple drug resistance TB 
(MDR-TB), resistant to the first line combination therapy 
of antibiotics is becoming fairly obvious with more than 
500 000 people in the world. Among those patients, about 
10% are predictable to be extensively drug resistant TB 
(XDR-TB), which is further resistant to a minimum one 
second-line therapy (4). XDR-TB occasionally needs a 
2-year course of antibiotics with a high cost and can be 
lethal even with proper treatment (5,6). 
Based on the fact of emerging MDR-TB and XDR-TB, 
there is a developing interest in the usage of medicinal 
plants that are complementary to antibiotics to improve 
anti-TB efficacy. Crude extracts of medicinal plants could 
act as another source of resistance modifying agents as a 
result of the wide variety of secondary metabolites that 
could act as potentials for antimicrobials. Plant extracts 
can bind to proteins causing inhibition of protein–protein 
interactions; making it effective modulators of host 
related immune response, mitosis, apoptosis and signal 
transduction (7). 
The genus Premna, family Lamiaceae, contains many 
species that are spread throughout tropical and subtropical 
areas. Premna species are used in traditional medicine 
to treat immune-related diseases, wound healing, 
inflammation, skin diseases, stomach disorders, as well as 
their antibacterial and antifungal activities (8).
In the Philippines, the leaves of Premna odorata Blanco 
are used in a wide variety of cultural applications in 
headache, fever, cough and cold. Many studies evaluated 
the activity of the leaves of P. odorata and their constituents 
against M. tuberculosis (9). Recently, P. odorata volatile oils 
(VOa) isolated from different plant organs (leaves, young 
stems, and flowers) showed significant anti-TB activities 
(10). Built on the above-mentioned facts; the present 
study aimed to continue this work and to test the possible 
involvement of toll-like receptor 4 (TLR-4)/nuclear factor-
κB (NF-κB) signaling pathway in the anti-TB efficacy of 
the VOs isolated from different parts of P. odorata in vivo. 
Materials and Methods
Chemicals and kits
All chemicals were of high analytical grade, obtained 
from Sigma Chemical Co., Ltd (St. Louis, MO, USA). All 
kits were the products of Cohesion biosciences limited 
(London, UK), CUSABIO (Wuhan, China), MyBioSource 
(San Diego, US). For conventional PCR targeting TRC4, 
the primer and red dye Master Mix kit were obtained from 
Bangalore Genei.
Plant materials
The plant was collected from The Zoo, Giza, Egypt, May; 
2017. It was generously identified by Dr. Abd El-Halim A. 
Mohammed, Horticultural Research Institute, Flora and 
Phytotaxonomy Researchers Department, Dokki, Cairo, 
Egypt. A voucher specimen (2016-BuPD 45) was placed 
at Department of Pharmacognosy, Faculty of Pharmacy, 
Beni-Suef University, Egypt.
Preparation of the volatile oils
As described previously (10), the fresh leaves, young 
stems and flowers (5 kg each) were submitted separately 
to a hydrodistillation process using Clevenger apparatus 
for 2 hours at 75°C. The oils were collected separately, 
dried over anhydrous sodium sulfate and stored at 4°C in 
air-tight amber glass containers. The yield (V/W %) was 
calculated based on the fresh weight of the plant material. 
The acute toxicity tests and GC/MS spectra of P. odorata 
VOs isolated from leaves, young stems and flowers were 
shown previously (10). 
Animals
Albino mice with an average body weight of 25-30 g were 
obtained from the Animal House; NODCAR; Giza; Egypt. 
The animals were separated into groups of five, fed with 
normal commercial pellet diet, given water ad libitum 
and maintained under standard conditions (temperature 
24–28°C, relative humidity 55%-10% and 12 h light–dark 
cycle).
In vivo MeDiPro Mycobacterium tuberculosis antigen 
ELISA technique
The effects of P. odorata VOs on the TB infected mice were 
evaluated. Thirty normal mice (25-30 g) were selected for 
this study and divided into six groups each contains five 
mice as follows:
• Group 1: Healthy mice (negative control), given 1 
ml saline. Five groups (Groups 2-6) of tuberculosis-
infected mice which were injected intravenously 
with a positive TB solution of purified MTB antigen 
ESAT-6 and CFP (20 μg/mL) using a dose of 100 μL/d 
for seven days. Mice which had sputum specimens 
positive for acid-fast bacilli (AFB) and/or culture 
positive for MTB were used in the experiment and 
classified in groups as follows:
• Group 2: Positive control untreated mice, given 1 mL 
saline. 
• Group 3: TB-injected mice treated orally through 
gavages with leaves oil using a dose of 300 μL/d.
• Group 4: TB-injected mice treated orally through 
gavages with young stems oil using a dose of 300 μL/d.
• Group 5: TB-injected mice treated orally through 
gavages with flowers oil using a dose of 300 μL/d.
• Group 6: TB-injected mice treated orally through 
gavages with combination of the three oils (1:1:1) 
using a dose of 300 μL/d.
After 15 days, mice were sacrificed by asphyxiation 
(CO2 dispensed from a regulated cylinder) followed 
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by decapitation. Blood samples were collected from the 
sublingual vein and were allowed to clot for 10 minutes 
prior to centrifugation at 3000 rpm for serum separation. 
Aliquots of serum samples for all groups were stored 
at -80°C for further determination of biochemical 
parameters.
Biochemical parameters of TLR4/NF-κB pathway
Assessment of serum levels of TNF-α 
Assessment of serum tumor necrosis factor-α (TNF-α) 
levels was determined using TNF-α ELISA Kit 
(MyBioSource, San Diego, USA). Briefly and following the 
company’s instructions, the assay was dependent on the 
technology of sandwich enzyme-linked immune-sorbent 
assay. Anti-TNFα polyclonal antibody was pre-covered on 
top of 96-well plates. The biotin conjugated anti-TNF-α 
polyclonal antibody was used as recognition antibody. The 
test samples, standards and biotin conjugated recognition 
antibody were added to the wells subsequently then 
washed with a washing buffer. A complex of Avidin-
Biotin-Peroxidase was added. Then a wash buffer was 
added to remove the unbound conjugates. Horseradish 
peroxidase (HRP) enzymatic reaction was visualized 
using TMB substrates. HRP catalyzed TMB to produce a 
blue color product which was changed to yellow after the 
addition of acidic stop solution. The amount of TNFα was 
proportional to the density of the yellow color captured 
in plate. In a microplate reader, the O.D. absorbance was 
read at 450 nm, and the TNFα concentration could be 
calculated.
Assessment of IL-10 serum levels
The assay of serum interleukin 10 (IL-10) was done using 
ELISA kit (CUSABIO, Wuhan, China). Briefly, antibody 
specific for IL-10 was pre-covered on top of a microplate. 
Standards and samples were pipetted into the wells 
and any present IL-10 was bound by the immobilized 
antibody. A biotin-conjugated antibody specific for IL-10 
was then added to the wells after removing any unbound 
substances. Then, avidin conjugated HRP was added to 
the wells. After washing to remove any unbound avidin-
enzyme reagent, a substrate solution was added to the 
wells. The color produced was proportional to the amount 
of IL-10 bound in the first step. The color development 
was stopped and the color intensity was measured.
Assessment of TAC serum levels 
Serum total antioxidant capacity (TAC) was determined 
by ELISA kit (MyBioSource, San Diego, US). Consistent 
with the manufacturer, the assay depends on the technique 
of competitive enzyme immunoassay using a monoclonal 
anti-TAC antibody and a TAC-HRP conjugate. The buffer 
and serum sample were incubated together for one hour 
with TAC-HRP conjugate in pre-coated plate. Afterward, 
the wells were emptied and washed five times. The wells 
were then incubated with HRP enzyme substrate to form 
a blue colored complex. At last, the solution turned yellow 
after adding a stop solution. In a microplate reader, the 
color intensity was measured spectrophotometrically at 
450 nm. The color intensity was inversely proportional to 
the concentration of TAC. A standard curve was plotted 
linking the intensity of the color (O.D.) to the standards’ 
concentration. The TAC concentration in each sample 
was introduced from the standard curve.
2.7.4 Assessment of IFN-γ serum levels
The interferon-gamma (IFN-γ) in serum samples was 
measured quantitatively using ELISA kit (Cohesion 
biosciences limited, London, UK). This assay employed 
an antibody specific for IFN-γ coated on a 96-well plate. 
Serum samples and standards were pipetted into the wells 
and IFN-γ presented in the sample was bound to the wells 
by the immobilized antibody. The wells were washed and 
biotinylated anti-Rat IFN-γ antibody was added. After 
washing away unbound biotinylated antibody, HRP-
conjugated streptavidin was added to the wells. The wells 
were again washed, and a TMB substrate solution was 
added to the wells. The developed color was comparable 
to the amount of IFN-γ bound. The intensity of the color 
changed from blue to yellow after the addition of the Stop 
Solution was measured at 450 nm.
Assessment of IL-1β serum levels
The serum IL-1β levels were determined by ELISA 
kit (CUSABIO, Wuhan, China). Briefly, IL-1β specific 
antibody was pre-coated on a microplate. Standards and 
serum samples (100 µL) were put into the wells and any 
IL-1β present was bound by the immobilized antibody. A 
biotin-conjugated IL-1β specific antibody was added to 
the wells after removing any unbound substances. Avidin 
conjugated HRP was added to the wells. Washing was done 
to remove any unbound avidin-enzyme reagent, then a 
substrate solution was added to the wells. Development 
of color was proportional to the amount of IL-1β bound 
in the initial step. The color development was stopped and 
the color intensity was measured.
Assessment of TLR-4 and NF-κB mRNA expression levels
Extraction of RNA
Total RNA was isolated by Trizol reagent (GIBCO BRL, 
Life Technologies, Inc., Grand Island, NY, USA).
Quantitative reverse transcriptase-PCR analysis
The absolute amounts of RNA were too small to be 
analyzed by Northern analysis. Half a microgram of the 
total RNA was used in each reverse transcriptase reaction. 
The quantitative PCR was driven by ABI PRISM 7700 
Sequence Detection System (Perkin Elmer, Norwalk, 
CT, U.S.A.). The primer sequences used for TLR4 were 
59-CCTCTGCCTTCACT ACAGAGACTTT-39 and 59- 
TGTGGAAGCCT TCCTGGATG-39, and the TaqMan 
probe sequence was 59(FAM)-CCTGGTGTAGCCA 
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TTGCTGCCAACA-(TAMRA). All results were 
normalized to 18S rRNA. While the primer sequence 
of NF-κB mRNA expression was forward primer: 
5′-ACAACCCC TTCCAAGTTCCCT-3′, and reverse 
primer (5′ TGGTCCCGTGA AATACACCT-3′). The 
comparative threshold cycle method was used to calculate 
relative expression of the studied genes. Normalization of 
all values to the GAPDH gene was done.
Statistical Analysis
The data were expressed as mean ± SE (standard error) 
and statistical analysis was carried out using the one-way 
ANOVA followed by Tukey test. A level of P < 0.05 was 
considered to be significant. The result was interpreted as 
positive infection for MTB antigen at a concentration >1.5 
μg/mL.
Results
Effects of different oil treatments on TNF-α serum levels
Mice which were injected intravenously with a dose of 
100 µL/d of positive TB solution of purified MTB antigen 
ESAT-6 and CFP (20 µg/mL), showed a significant 10-fold 
increase in TNF-α serum levels, as compared to the normal 
healthy mice. Treatment of the infected mice with leaves 
oil, flowers oil and young stem oil markedly reduced the 
TNF-α serum levels by 51%, 69% and 62%, respectively, 
as compared to TB-infected mice. While the combination 
of the three oils (1:1:1) caused a normalization of TNF-α 
serum level (92% decrease, as compared to healthy mice) 
(Figure 1).
Effects of different oil treatments on IL-10 serum levels
TB-infected mice showed a marked decrease (~78%) in 
IL-10 serum levels, when compared to the normal healthy 
mice (Figure 2). The oral treatment with oils extracted 
from leaves, flowers, young stem, or the combination of 
the three oils significantly reversed the IL-10 levels by 2.2, 
3.6, 3 and 5-fold increase, respectively, as compared to TB-
infected mice.
Effects of different oil treatments on TAC serum levels
The infection with TB solution obviously reduced the 
serum TAC in mice by 83%, as compared with healthy 
mice. VOs extracted from leaves, flowers and young stems 
caused a significant increase of serum TAC in the infected 
mice by 3.3, 5 and 4.3-folds, respectively, the combination 
of the three oils showed the highest increase in serum 
TAC (7.5-fold increase), as compared to the TB-infected 
rats, (Figure 3).
Effects of different oil treatments on IFN-γ serum levels
TB infection of healthy mice significantly increased the 
INF-γ serum level by 12.7 folds. When these mice were 
treated with P. odorata VOs extracted from leaves, flowers 
and young stems, INF-γ serum levels markedly reduced 
by 57, 79 and 70%, respectively, while the combination of 
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Fig. 1. Effect of treatment of TB-infected mice with P. odorata volatile oils 
(300µl/d; p.o, 15 days) extracted from leaves, flowers, young stem or a 
combination of the three oils (1:1:1) on serum levels of TNF-α. Values are means 
of 5 mice ± SEM. As compared to normal healthy mice (*), TB-infected mice (@), 
TB-infected mice treated with leaves oil (#), TB-infected mice treated with flowers 
oil (^), TB-infected mice treated with young stem oil ($) and TB-infected mice 
treated with a combination of the three oils (one-way ANOVA followed by Tukey’s 
post-hoc test); p< 0.05.  
 
Effects of different oil treatments on IL-10 serum levels 
TB-infected mice showed a marked decrease (~78%) in IL-10 serum levels, when 
compared to the normal healthy mice (Figure 2). The oral treatment with oils 
extracted from leaves, flowers, young stem, or the combination of the three oils 
significantly reversed the IL-10 levels by 2.2, 3.6, 3 and 5-fold increase, 
respectively, as compared to TB-infected mice. 
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Figure 2. Effect of treatment of TB-infected mice with P. odorata 
volatile oils (300 µL/d; p.o, 15 days) extracted from leaves, 
flowers, young stem or a combination of the three oils (1:1:1) on 
serum levels of IL-10. Values are means of 5 mice ± SEM. As 
compared to normal healthy mice (*), TB-infected mice (@), TB-
infected mice treated with leaves oil (#), TB-infected mice treated 
with flowers oil (^), TB-infected mice treated with young stem 
oil ($) and TB-infected mice treated with a combination of the 
three oils (one-way ANOVA followed by Tukey’s post-hoc test); 
P < 0.05. 
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Fig. 2. Effect of reatment of TB-infected mice with P. odorata volatile oils 
(300µl/d; p.o, 15 days) extracted from leaves, flowers, young stem or a 
combination of the three oils (1:1:1) on serum levels of IL-10. Values are means of 
5 mice ± SEM. As compared to normal healthy mice (*), TB-infected mice (@), TB-
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Effects of different oil treatments on TAC serum levels 
 The infection with TB solution obviously reduced the serum TAC in mice by 83%, 
as ompared with healthy mice. VOs extracted from leaves, flowers and young stems 
caused a significant increase of serum TAC in the infected mice by 3.3, 5 and 4.3-
folds, respectively, the combination of the three oils showed the highest increase in 
serum TAC (7.5-fold increase), as compared to the TB-infected rats, (Figure 3). 
the three oils returned the INF-γ serum levels of infected 
mice back to normal (Figure 4).
Effects of different oil treatments on IL-1β serum levels 
As illustrated in Figure 5, Interleukin-1β serum levels 
wer  noticeably increased in TB-infected mice by 7.4 
folds, as compared to the serum levels in normal mice. 
Oral treatment with leaves oil, flowers oil and young stems 
oil considerably reduced IL-1β serum levels by 70%, 74% 
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and 65%, respectively. Similarly, the three oil combination 
therapy had the highest effect as it was able to return IL-1β 
to normal mice serum levels.
Effects of different oil treatments on mRNA expression 
levels of TLR-4
As highlighted in Figure 6, Toll-like receptor-4 (TLR4) 
relative expression levels were greatly increased (~6 folds) 
in TB-infected mice, as compared to normal mice. The 
VO treatment extensively reduced TLR-4 serum levels by 
58% (leaves oil), 73% (flowers oil), 67% (young stems oil) 
and 80% (combination of three oils), when compared with 
infected mice.
Figure 3 Effect of treatment of TB-infected mice with P. odorata 
volatile oils (300 µL/d; p.o, 15 days) extracted from leaves, flowers, 
young stem or a combination of the three oils (1:1:1) on TAC serum 
levels. Values are means of 5 mice ± SEM. As compared to normal 
healthy mice (*), TB-infected mice (@), TB-infected mice treated with 
leaves oil (#), TB-infected mice treated with flowers oil (^), TB-infected 
mice treated with young stem oil ($) and TB-infected mice treated with 
a combination of the three oils (one-way ANOVA followed by Tukey’s 
post-hoc test); P < 0.05. 
Figure 4. Effect of treatment of TB-infected mice with P. odorata 
volatile oils (300 µL/d; p.o, 15 days) extracted from leaves, flowers, 
young stem or a combination of the three oils (1:1:1) on serum levels 
of INF-γ. Values are means of 5 mice ± SEM. As compared to normal 
healthy mice (*), TB-infected mice (@), TB-infected mice treated with 
leaves oil (#), TB-infected mice treated with flowers oil (^), TB-infected 
mice treated with young stem oil ($) and TB-infected mice treated with 
a combination of the three oils (one-way ANOVA followed by Tukey’s 
post-hoc test); P < 0.05. 
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Fig. 3 Effect of treatment of TB-infected mice with P. odorata volatile oils 
(300µl/d; p.o, 15 days) extracted from leaves, flowers, young stem or a 
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mice ± SEM. As compared to normal h althy mice (*), TB-inf ct  mice (@), TB-
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p< 0.05.  
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TB infection of healthy mice significantly increased the INF-γ serum level by 12.7 
folds. When these mice were treated with P. odorata VOs extracted from leaves, 
flowers and young stems, INF-γ serum levels markedly reduced by 57, 79 and 70%, 
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of infected mice back to normal (Figure 4). 
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Fig. 4. Effect of treatment of TB-infected mice with P. odorata volatile oils 
(300µl/d; p.o, 15 days) extracted from leaves, flowers, young stem or a 
combination of the three oils (1:1:1) on serum levels of INF-γ. Values are means of 
5 mice ± SEM. As compared to normal healthy mice (*), TB-infected mice (@), TB-
infected mice treated with leaves oil (#), TB-infected mice treated with flowers oil (^), 
TB-infected mice treated with young stem oil ($) and TB-infe ted mice treated with a 
combination of the three ils (one-way ANOVA followed by Tukey’s post-hoc test); 
p< 0.05.  
 
Effects of different oil treatments on IL-1β serum levels  
As illustrated in Figure 5, Interleukin-1β serum levels were noticeably increased in 
TB-infected mice by 7.4 folds, as compared to the serum levels in normal mice. Oral 
treatment with leaves oil, flowers oil and young stems oil considerably reduced IL-
1β serum levels by 70%, 74% and 65%, respectively. Similarly, the three oil 
combination therapy had the highest effect as it was able to return IL-1β to normal 
mice serum levels. 
Effects of different oil treatments on mRNA expression 
levels of NF-κB
In the same way, the TB-infected mice exhibited an 
increase in mRNA expression levels of NF-κB by about 
19 folds. Oral administration of P. odorata VOs extracted 
from leaves, flowers and young stem oils caused an 
observable decrease of mRNA expression levels of NF-κB 
by 56, 78 and 45%, respectively. Again, the combination 
of the three oils presented a massive decrease in NF-κB 
expression levels to the degree that reached to normal 
levels, as evident in Figure 7.
Discussion
The results of the present study revealed novel 
immunomodulatory effects of P. odorata VOs in TB 
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Fig. 5. Effect of treatment of TB-infected mice with P. odorata volatile oils 
(300µl/d; p.o, 15 days) extracted from leaves, flowers, young stem or a 
combination of the three oils (1:1:1) on serum levels of IL-1β. Values are means of 
5 mice ± SEM. As compared to normal healthy mice (*), TB-infected mice (@), TB-
infected mice treated with leaves oil (#), TB-infected mice treated with flowers oil (^), 
TB-infected mice treated with young stem oil ($) and TB-infected mice treated with a 
combination of the three oils (one-way ANOVA followed by Tukey’s post-hoc test); 
p< 0.05.  
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were greatly increased (~6 folds) in TB-infected mice, as compared to normal mice. 
The VO treatment extensively reduced TLR-4 serum levels by 58% (leaves oil), 
73% (flowers oil), 67% (young stems oil) and 80% (combination of three oils), when 
compared with infected mice. 
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Fig. 6. Effect of treatment of TB-infected mice with P. odorata volatile oils 
(300µl/d; p.o, 15 days) extracted from leaves, flowers, young stem or a 
combination of the three oils (1:1:1) on mRNA expression levels of TLR-4. 
Values are means of 5 mice ± SEM. As compared to normal healthy mice (*), TB-
infected mice (@), TB-infected mice treated with leaves oil (#), TB-infected mice 
treated with flowers oil (^), TB-infected mice treated with young stem oil ($) and TB-
infected mice treated with a combination of the three oils (one-way ANOVA followed 
by Tukey’s post-hoc test); p< 0.05.  
 
Effects of different oil treatments on mRNA expression levels of NF-κB 
In the same way, the TB-infected mice exhibited an increase in mRNA expression 
levels of NF-κB by about 19 folds. Oral administration of P. odorata VOs extracted 
from leaves, flowers and young stem oils caused an observable decrease of mRNA 
expression levels of NF-κB by 56, 78 and 45%, respectively. Again, the combination 
of the three oils presented a massive decrease in NF-κB expression levels to the 
degree that reached to normal levels, as evident in Figure 7. 
Figure 6. Effect of treatment of TB-infected mice with P. odorata 
vola ile oils (300 µL/d; p.o, 15 days) extra t d from leaves, flowers, 
young stem or a combination of the three oils (1:1:1) on mRNA 
expression levels of TLR-4. Values are means of 5 mice ± SEM. 
As compared to normal healthy mice (*), TB-infected mice (@), TB-
infected mice treated with leaves oil (#), TB-infected mice treated with 
flowers oil (^), TB-infected mice treated with young stem oil ($) and 
TB-infected mice treated with a combination of the three oils (one-way 
ANOVA followed by Tukey’s post-hoc test); P < 0.05. 
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infected mice, evidenced by amelioration of the increased 
expression levels of TLR-4 and NF-κB. TLRs have a vital 
role in the host immune responses against mycobacterial 
infection and that they are involved in not only immune 
cells but also other cells. These transmembrane proteins 
induce a natural immune response to many pathogens. 
Among them, TLR-2 and TLR-4 that have been identified 
in association with tuberculosis infection by recognizing 
various ligands with a lipoprotein structure in the bacilli, 
then antimicrobial proteins and inflammatory cytokines 
are synthesized (11). 
In a similar pattern, previous studies showed that 
tuberculosis bacilli stimulate the expression of TLR-
4 (12,13), a finding that proven herein. Stimulation of 
TLRs by mycobacterial ligands leads to an initiation 
of intracellular signaling cascades that culminate in 
17 
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expression of TLR-4 (12,13), a finding that proven herein. Stimulation of TLRs by 
Figure 7. Effect of treatment of TB-infected mice with P. odorata 
volatile oils (300 µL/d; p.o, 15 days) extracted from leaves, flowers, 
young stem or a combination of the three oils (1:1:1) on mRNA 
expression levels of NF-κB. Values are means of 5 mice ± SEM. 
As compared to normal healthy mice (*), TB-infected mice (@), TB-
infected mice treated with leaves oil (#), TB-infected mice treated with 
flowers oil (^), TB-infected mice treated with young stem oil ($) and 
TB-infected mice treated with a combination of the three oils (one-way 
ANOVA followed by Tukey’s post-hoc test); P < 0.05. 
the activation of NF-kB, similar to our finding, which 
then translocate to the nucleus to regulate target gene 
expression and play important roles in orchestrating 
proinflammatory responses and innate defense by 
generation of a variety of antimicrobial effector molecules 
like TNF-α, IL-1β & IFN-γ in addition to the reduction 
in TAC. Likewise, in the present study, the overexpression 
of both TLR-4 as well as NF-κβ in TB-infected mice was 
accompanied by a subsequent increase in serum levels 
of TNF-α, IL-1β, INF-γ and also a decreased TAC level. 
Decreased TAC levels have been reported in TB patients 
because of the defect in the host antioxidant defenses and 
the subsequent oxidative stress, which can be partially 
restored with antioxidant treatment in addition to 
malnutrition and poor immunity in these patients (14,15). 
The treatment of TB-infected mice with the VOs extracted 
from different plant organs overturned all those previous 
effects on TNF-α, IL-1β and INF-γ serum levels, it also 
increased serum TAC levels suggesting the antioxidant 
activity of P. odorata that also was proved in other studies 
(16,17). All these effects are suggesting the involvement of 
TLR-4/ NF-κβ cascade in the anti-tuberculosis effects of 
P. odorata VOs. 
IL-10 is an inhibitory and anti-inflammatory 
cytokine that inhibits the ability of myeloid cells such 
as macrophages and dendritic cells to activate cytokine 
production from Th1 cells such as TNF-α & IFN-γ. Thus 
IL-10 is an immunosuppressive cytokine that can inhibit 
macrophage functions, resulting in enhanced intracellular 
bacterial growth (18,19). Thus, the balance between 
TNF-α & IFN-γ and IL-10 produced by macrophages 
against TB is thought to modulate immune response 
against TB infection (20,21). This was evident by TB 
antigen –induced increase in both IFN-γ and TNF-α 
produced by Th1 cells and a decrease in IL-10 produced 
Figure 8. The inhibitory effect of Premna odorata volatile oils on TLR4/NF-κB pathway during Mycobacterium tuberculosis infection.
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by Th2 cells; effects that were reversed by the use of VOs 
extracted from different plant organs. These targets are 
illustrated in (Figure 8), highlighting the mechanistic 
approach, through which the VOs were functioning.
Conclusion
Accordingly, the results of the present study suggest that 
the immunomodulatory effects of VOs extracted from 
the leaves, flowers, stems and combinations of the three 
extracts (1:1:1) of P. odorata against TB infection involve 
the TLR-4/NFκB signaling pathway as well as, antioxidant 
effects, recommending that the use of this plant may help 
TB infected patients.
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